Vantage BioTrials Awarded “Excellence in Phase I-IV Clinical Trial Management Services”
November 21, 2016, Montréal, Canada – Vantage BioTrials has yet again been awarded for its passion and commitment in providing its clients and patients quality clinical trial management through the recognition of Corporate LiveWire Magazine in the category of Excellence in Phase I-IV Clinical Trial Management Services in their 2016 Healthcare and Life Sciences Award series.
“After winning the International Life Sciences Award earlier this year, this new award was not anticipated but highly welcomed. We are humbled to receive this recognition as it is a testament of our efforts leading up to our tenth year anniversary” said Viken Bartekian, Co-Founder and Vice-President of Corporate Development at Vantage BioTrials. Bartekian continued to add, “Through our team’s hard work, passion and dedication, we are setting a precedence that small CRO’s such as Vantage BioTrials can compete in this ever growing global market and offer the quality and expertise to run highly complicated clinical studies across all phases of development. We have expanded our capacity in the area of Post Market Observational Studies (PMOS) and Medical Device trials due to the changing and innovative healthcare landscape within Canada. We look forward to working closely with our sponsors, partners and investigators in order to continue bringing safe and effective therapies to patients.”